FUJIFILM Healthcare Americas Corporation: Device Recall
Recall #Z-2219-2025 · 06/11/2025
Class II: Risk
Recall Details
- Recall Number
- Z-2219-2025
- Classification
- Class II
- Product Type
- Device
- Recalling Firm
- FUJIFILM Healthcare Americas Corporation
- Status
- Ongoing
- Date Initiated
- 06/11/2025
- Location
- Lexington, MA, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 293 units
Reason for Recall
Devices had an unapproved slabbing software function enabled for use.
Product Description
ASPRIRE Cristalle Mammography System (cleared under K212873) installed with the ASPIRE Cristalle Digital Breast Tomosynthesis (DBT) Option (approved under P160031).
Distribution Pattern
Worldwide distribution - US Nationwide and the countries of Canada, Chile, Ecuador.
Other Recalls by FUJIFILM Healthcare Americas Corporation
- Class II: Risk 01/09/2026
- Class II: Risk 09/15/2025
- Class II: Risk 02/11/2025
View all recalls by FUJIFILM Healthcare Americas Corporation →
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.